Cargando…
Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID‐...
Autores principales: | Alislambouli, Mawaddah, Veras Victoria, Andy, Matta, Jyoti, Yin, Faye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657522/ https://www.ncbi.nlm.nih.gov/pubmed/34909764 http://dx.doi.org/10.1002/jha2.342 |
Ejemplares similares
-
Covid-19-vaccine-pfizer-biontech: Thrombotic thrombocytopenic purpura: case report
Publicado: (2021) -
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine
por: Giuffrida, Gaetano, et al.
Publicado: (2021) -
Covid-19 vaccine pfizer biontech: Immune-mediated thrombotic thrombocytopenic purpura: case report
Publicado: (2021) -
Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020) -
Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination
por: Francisco, Michael T., et al.
Publicado: (2021)